# Wells Fargo & Company: financial statements, quarterly

WFC · NYSE · CIK 72971 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wfc.md) · [Financials](/companies/wfc/financials.md) · [Filings](/companies/wfc/filings.md) · [Insiders](/companies/wfc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wfc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [20.5 d](/filings/0000072971-26-000133.md) | [20.9](/filings/0000072971-25-000129.md) | [20.7](/filings/0000072971-25-000201.md) | [20.4](/filings/0000072971-25-000253.md) | [20.4 d](/filings/0000072971-26-000133.md) | [20.1](/filings/0000072971-26-000217.md) | [20.8](/filings/0000072971-26-000302.md) | [21.4](/filings/0000072971-26-000327.md) | [21.3 d](/filings/0000072971-26-000133.md) | [21.4](/filings/0000072971-26-000217.md) | [22.6](/filings/0000072971-26-000302.md) | [21.9](/filings/0000072971-26-000327.md) |
| Interest expense | $bn | [10.1 d](/filings/0000072971-24-000064.md) | [10.6](/filings/0000072971-24-000129.md) | [11.0](/filings/0000072971-24-000185.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [(0.1) d](/filings/0000072971-26-000133.md) | [1.0](/filings/0000072971-25-000129.md) | [1.3](/filings/0000072971-25-000201.md) | [1.1](/filings/0000072971-25-000253.md) | [0.1 d](/filings/0000072971-26-000133.md) | [0.5](/filings/0000072971-26-000217.md) | [0.9](/filings/0000072971-26-000302.md) | [1.3](/filings/0000072971-26-000327.md) | [1.1 d](/filings/0000072971-26-000133.md) | [0.7](/filings/0000072971-26-000217.md) | [1.4](/filings/0000072971-26-000302.md) | [1.2](/filings/0000072971-26-000327.md) |
| Net income | $bn | [3.4 d](/filings/0000072971-26-000133.md) | [4.6](/filings/0000072971-25-000129.md) | [4.9](/filings/0000072971-25-000201.md) | [5.1](/filings/0000072971-25-000253.md) | [5.1 d](/filings/0000072971-26-000133.md) | [4.9](/filings/0000072971-26-000217.md) | [5.5](/filings/0000072971-26-000302.md) | [5.6](/filings/0000072971-26-000327.md) | [5.4 d](/filings/0000072971-26-000133.md) | [5.3](/filings/0000072971-26-000217.md) | [6.4](/filings/0000072971-26-000302.md) | [6.0](/filings/0000072971-26-000327.md) |
| Diluted EPS | $ per share | not reported | [1.20](/filings/0000072971-25-000129.md) | [1.33](/filings/0000072971-25-000201.md) | [1.42](/filings/0000072971-25-000253.md) | not reported | [1.39](/filings/0000072971-26-000217.md) | [1.60](/filings/0000072971-26-000302.md) | [1.66](/filings/0000072971-26-000327.md) | not reported | [1.60](/filings/0000072971-26-000217.md) | [2.00](/filings/0000072971-26-000302.md) | [1.87](/filings/0000072971-26-000327.md) |
| Basic EPS | $ per share | not reported | [1.21](/filings/0000072971-25-000129.md) | [1.35](/filings/0000072971-25-000201.md) | [1.43](/filings/0000072971-25-000253.md) | not reported | [1.41](/filings/0000072971-26-000217.md) | [1.61](/filings/0000072971-26-000302.md) | [1.68](/filings/0000072971-26-000327.md) | not reported | [1.62](/filings/0000072971-26-000217.md) | [2.02](/filings/0000072971-26-000302.md) | [1.89](/filings/0000072971-26-000327.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $bn | [1,932](/filings/0000072971-25-000066.md) | [1,959](/filings/0000072971-25-000129.md) | [1,940](/filings/0000072971-25-000201.md) | [1,922](/filings/0000072971-25-000253.md) | [1,930](/filings/0000072971-26-000133.md) | [1,950](/filings/0000072971-26-000217.md) | [1,981](/filings/0000072971-26-000302.md) | [2,063](/filings/0000072971-26-000327.md) | [2,149](/filings/0000072971-26-000327.md) | [2,206](/filings/0000072971-26-000217.md) | [2,282](/filings/0000072971-26-000302.md) | [2,253](/filings/0000072971-26-000327.md) |
| Total liabilities | $bn | [1,745](/filings/0000072971-25-000066.md) | [1,776](/filings/0000072971-24-000129.md) | [1,762](/filings/0000072971-24-000185.md) | [1,737](/filings/0000072971-24-000243.md) | [1,749](/filings/0000072971-26-000133.md) | [1,767](/filings/0000072971-25-000129.md) | [1,798](/filings/0000072971-25-000201.md) | [1,880](/filings/0000072971-25-000253.md) | [1,966](/filings/0000072971-26-000327.md) | [2,025](/filings/0000072971-26-000217.md) | [2,100](/filings/0000072971-26-000302.md) | [2,075](/filings/0000072971-26-000327.md) |
| Long-term debt | $bn | [208](/filings/0000072971-25-000066.md) | [188](/filings/0000072971-24-000129.md) | [179](/filings/0000072971-24-000185.md) | [182](/filings/0000072971-24-000243.md) | [173](/filings/0000072971-26-000133.md) | [174](/filings/0000072971-25-000129.md) | [176](/filings/0000072971-25-000201.md) | [178](/filings/0000072971-25-000253.md) | [175](/filings/0000072971-26-000327.md) | [184](/filings/0000072971-26-000217.md) | [182](/filings/0000072971-26-000302.md) | [183](/filings/0000072971-26-000327.md) |
| Short-term borrowings | $bn | [89.6](/filings/0000072971-25-000066.md) | [109](/filings/0000072971-24-000129.md) | [119](/filings/0000072971-24-000185.md) | [112](/filings/0000072971-24-000243.md) | [2.7](/filings/0000072971-26-000133.md) | [140](/filings/0000072971-25-000129.md) | [188](/filings/0000072971-25-000201.md) | [231](/filings/0000072971-25-000253.md) | [18.3](/filings/0000072971-26-000327.md) | [32.3](/filings/0000072971-26-000217.md) | [25.2](/filings/0000072971-26-000302.md) | [38.2](/filings/0000072971-26-000327.md) |
| Shareholders' equity | $bn | [186](/filings/0000072971-25-000066.md) | [181](/filings/0000072971-24-000129.md) | [176](/filings/0000072971-24-000185.md) | [183](/filings/0000072971-24-000243.md) | [179](/filings/0000072971-26-000133.md) | [181](/filings/0000072971-25-000129.md) | [181](/filings/0000072971-25-000201.md) | [181](/filings/0000072971-25-000253.md) | [181](/filings/0000072971-26-000327.md) | [178](/filings/0000072971-26-000217.md) | [180](/filings/0000072971-26-000302.md) | [176](/filings/0000072971-26-000327.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [18.2 d](/filings/0000072971-26-000133.md) | [(12.1)](/filings/0000072971-25-000129.md) | [2.1 d](/filings/0000072971-25-000201.md) | [4.2 d](/filings/0000072971-25-000253.md) | [8.9 d](/filings/0000072971-26-000133.md) | [(11.0)](/filings/0000072971-26-000217.md) | [(11.2) d](/filings/0000072971-26-000302.md) | [(0.9) d](/filings/0000072971-26-000327.md) | [4.1 d](/filings/0000072971-26-000133.md) | [9.1](/filings/0000072971-26-000217.md) | [6.8 d](/filings/0000072971-26-000302.md) | [8.9 d](/filings/0000072971-26-000327.md) |
| Dividends paid | $bn | [1.3 d](/filings/0000072971-26-000133.md) | [1.2](/filings/0000072971-25-000129.md) | [1.2 d](/filings/0000072971-25-000201.md) | [1.4 d](/filings/0000072971-25-000253.md) | [1.3 d](/filings/0000072971-26-000133.md) | [1.3](/filings/0000072971-26-000217.md) | [1.3 d](/filings/0000072971-26-000302.md) | [1.4 d](/filings/0000072971-26-000327.md) | [1.4 d](/filings/0000072971-26-000133.md) | [1.4](/filings/0000072971-26-000217.md) | [1.4 d](/filings/0000072971-26-000302.md) | [1.5 d](/filings/0000072971-26-000327.md) |
| Share repurchases | $bn | [2.4 d](/filings/0000072971-26-000133.md) | [6.0](/filings/0000072971-25-000129.md) | [6.0 d](/filings/0000072971-25-000201.md) | [3.4 d](/filings/0000072971-25-000253.md) | [4.0 d](/filings/0000072971-26-000133.md) | [3.5](/filings/0000072971-26-000217.md) | [3.0 d](/filings/0000072971-26-000302.md) | [6.0 d](/filings/0000072971-26-000327.md) | [5.0 d](/filings/0000072971-26-000133.md) | [4.0](/filings/0000072971-26-000217.md) | [3.0 d](/filings/0000072971-26-000302.md) | [2.5 d](/filings/0000072971-26-000327.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3,819](/filings/0000072971-24-000129.md) | [3,725](/filings/0000072971-24-000185.md) | [3,681](/filings/0000072971-24-000243.md) | [3,600](/filings/0000072971-25-000129.md) | [3,486](/filings/0000072971-25-000201.md) | [3,425](/filings/0000072971-25-000253.md) | [3,322](/filings/0000072971-26-000217.md) | [3,267](/filings/0000072971-26-000302.md) | [3,224](/filings/0000072971-26-000327.md) | [3,118](/filings/0000072971-26-000217.md) | [3,075](/filings/0000072971-26-000302.md) | [3,052](/filings/0000072971-26-000327.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,001,850,317 at 2026-10-19, from the cover of the [10-Q filed 2026-10-28](/filings/0000072971-26-000327.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 05:11 ET. No prices; not investment advice.